CAS: 940002-59-5 - β-D-Glucopyranuronic acid, 1-[N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamate]

Fórmula: C₂₃H₂₃F₆N₅O₉

InChI: InChI=1S/C23H23F6N5O9/c24-10-6-12(26)11(25)4-8(10)3-9(30-22(41)43-20-17(38)15(36)16(37)18(42-20)19(39)40)5-14(35)33-1-2-34-13(7-33)31-32-21(34)23(27,28)29/h4,6,9,15-18,20,36-38H,1-3,5,7H2,(H,30,41)(H,39,40)/t9-,15+,16+,17-,18+,20+/m1/s1

Chave InChI: InChIKey=GKDZQUQEXZXGMZ-KUVPMCASSA-N

SMILES: O=C(OC1OC(C(=O)O)C(O)C(O)C1O)NC(CC(=O)N2CC3=NN=C(N3CC2)C(F)(F)F)CC4=CC(F)=C(F)C=C4F

Sinónimos:

• β-D-Glucopyranuronic acid, 1-[N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamate]

Sitagliptin Carbamoyl Glucuronide

CAS: 940002-59-5

• Fórmula: C₂₃H₂₃F₆N₅O₉
• Cor e Forma: Pale Yellow To Off-White Solid
• Peso molecular: 627.45

(-)-Sitagliptin Carbamoyl Glucuronide

CAS: 940002-59-5

Minor phase II metabolite of DPP-4 inhibitor sitagliptin, found in rat and dog plasma.

• Fórmula: C₂₃H₂₃F₆N₅O₉
• Cor e Forma: Liquid
• Peso molecular: 627.453

Sitagliptin carbamoyl b-D-glucuronide

CAS: 940002-59-5

Sitagliptin Carbamoyl β-D-Glucuronide Sodium Salt

CAS: 940002-59-5

• Fórmula: C₂₃H₂₂F₆N₅NaO₉
• Cor e Forma: Neat
• Peso molecular: 649.43

Sitagliptin carbamoyl b-D-glucuronide

CAS: 940002-59-5

Sitagliptin carbamoyl b-D-glucuronide is a synthetic drug that has been modified to be sitagliptin, which …

• Fórmula: C₂₃H₂₃F₆N₅O₉
• Pureza: Min. 95%
• Peso molecular: 627.45 g/mol